Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma.

Yoshiharu OkuyamaShingo Hatakeyama Kazuyuki NumakuraTakuma NaritaToshikazu TanakaYuki MiuraDaichi SasakiDaisuke NoroNoriko TokuiTeppei OkamotoHayato YamamotoShintaro NaritaTakahiro YoneyamaYasuhiro HashimotoTomonori HabuchiChikara Ohyama

Published in: BJUI compass (2021)

The concomitant use of PPI may adversely affect oncological outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with ICI therapy.

Keyphrases

locally advanced
rectal cancer
squamous cell carcinoma
neoadjuvant chemotherapy
small cell lung cancer
phase ii study
radiation therapy
protein protein
stem cells
prostate cancer
type diabetes
small molecule
lymph node
bone marrow
smoking cessation